Cervical Polyp Found During IUI Planning in Siliguri: Remove or Monitor?

Cervical polyps arise on or within the cervix and may cause spotting, bleeding after intercourse or no symptoms at all. They can sometimes be seen during a speculum examination, while imaging may help clarify whether a lesion actually originates inside the uterine cavity. Screening history and any concerning symptoms matter. A growth observed on the cervix should not automatically be labelled an implantation problem or the cause of infertility. Equally, unexplained persistent bleeding should not be dismissed merely because a polyp has been seen. The full clinical context determines whether removal, pathology or further assessment is appropriate.

Ask the examining clinician to record the polyp's location, appearance, whether the cervix is inflamed and whether there is bleeding or a previous abnormal cervical screening result. Discuss the possibility of pregnancy and current cycle medications before any procedure. If removal is recommended, ask whether tissue will be examined, what risks and aftercare apply, and whether treatment should be deferred until healing is assessed. There is no sound reason to schedule routine hysteroscopy solely because every cervical polyp must be treated as a uterine lesion. Make sure the diagnosis is anatomically specific.

The team may monitor a reassuring, asymptomatic finding, remove a symptomatic or concerning polyp, or investigate an uncertain lesion further. Where the polyp obstructs catheter passage or there is bleeding that makes a procedure difficult, the IUI plan may need alteration. The decision should balance symptom evaluation, procedure risks, cost and how much the finding truly changes reproductive care. If the patient is undergoing ovarian stimulation, ask what happens to the cycle if IUI is postponed rather than treating it as a minor administrative change. The clinician should describe the rationale in plain language and obtain consent.

One patient has a small cervical polyp without symptoms, discovered incidentally during a routine fertility examination. Another has recurrent bleeding after intercourse and a lesion with an uncertain appearance. A blanket instruction to remove both immediately, or to ignore both, would not be good medicine. Ask for a plan that names the observed finding, explains the specific concern and states whether insemination can safely proceed. If removal is planned, check when the patient can return for further treatment and what symptoms after the procedure should trigger a call.

If you are arranging care from Sevoke Road, Siliguri, keep a written plan that distinguishes the clinical decision from the journey to the facility. For cervical polyp, the key question is whether a remote discussion will clarify existing findings or a qualified examination is actually required. Do not book a test only because it appears in a package; ask what its result would change. For an IUI-related concern, record the actual stimulation medicines, follicle-monitoring report, trigger date if applicable, insemination time and the planned pregnancy-test date. Keep a direct contact for questions arising after the procedure. Because symptoms and results can be misleading without timing, a short accurate timeline may be more useful than repeated at-home testing. Do not reschedule an insemination or a trigger on administrative advice alone.

HomeIVF’s intended model is doctor-led fertility care with fewer unnecessary clinic visits, not IVF performed inside a residence. Where clinically appropriate and locally available, some consultations, record review, selected blood collection, medication or injection support, follow-up and coordination may be organised at or near home. Availability must be checked for the actual patient, address and service; no city page should promise a provider or nurse without confirmation. The clinical team should explain which reports they will accept and who is responsible for acting on abnormal results.

Ultrasound when necessary, egg retrieval, anaesthesia, embryology and embryo transfer are facility-based. Any IUI, uterine procedure or special examination relevant to the issue must also use an appropriate clinical setting. An offer of at-home injection support does not mean the actual procedure, monitoring or safety response can happen in a bedroom or on a video call.

Heavy bleeding, persistent unexplained bleeding, fever, severe pelvic pain or other acute symptoms require medical evaluation. Do not attempt home removal or self-treatment. A pelvic or speculum examination, polyp procedure, pathology review and IUI must happen with appropriate clinical care. An online page must not invent local procedure capacity, provider names or an assurance that treatment will not be delayed.

• What does my existing cervical polyp evidence show, and what does it not show?
• Which next step would change management rather than simply add another report?
• Which examination or procedure must happen at a suitable facility for this iui concern?
• If the plan changes, who explains medicines, consent, timing and cost?
• What symptoms or result require an urgent call rather than a routine follow-up?